Get the Stockscreener App
100.72
0.15%
0.15
After Hours:
100.97
0.25
+0.25%
Boston Scientific Corp stock is traded at $100.72, with a volume of 7.27M.
It is up +0.15% in the last 24 hours and up +3.17% over the past month.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
See More
Previous Close:
$100.57
Open:
$100.41
24h Volume:
7.27M
Relative Volume:
0.86
Market Cap:
$149.24B
Revenue:
$19.35B
Net Income/Loss:
$2.78B
P/E Ratio:
53.87
EPS:
1.8696
Net Cash Flow:
$3.49B
1W Performance:
-0.39%
1M Performance:
+3.17%
6M Performance:
-2.09%
1Y Performance:
+19.88%
1-Day Range:
$99.94
$101.15
1-Week Range:
$99.72
$102.86
52-Week Range:
$83.50
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Name
Boston Scientific Corp
Sector
Industry
Phone
508-683-4000
Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
100.72 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
ABT
Abbott Laboratories
|
123.62 | 216.79B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
356.24 | 141.06B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.70 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.45 | 49.01B | 5.88B | 1.34B | 577.90M | 2.3455 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-03-25 | Downgrade | Erste Group | Buy → Hold |
| Sep-08-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jun-16-25 | Initiated | Leerink Partners | Outperform |
| Apr-16-25 | Upgrade | Needham | Hold → Buy |
| Jan-10-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Oct-18-24 | Downgrade | Needham | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| Feb-01-24 | Upgrade | Mizuho | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-22-22 | Initiated | Mizuho | Neutral |
| Dec-20-22 | Resumed | Citigroup | Buy |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-27-22 | Upgrade | Needham | Hold → Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| May-26-21 | Downgrade | Needham | Buy → Hold |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-22-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-01-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Buy |
| Dec-30-19 | Reiterated | Cowen | Outperform |
| Dec-19-19 | Downgrade | Needham | Strong Buy → Buy |
| Sep-05-19 | Resumed | JP Morgan | Overweight |
| Sep-03-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Oct-02-18 | Reiterated | Morgan Stanley | Overweight |
| Sep-07-18 | Reiterated | Needham | Strong Buy |
| Sep-04-18 | Upgrade | Jefferies | Hold → Buy |
| Jul-06-18 | Reiterated | Needham | Strong Buy |
| Jun-27-18 | Initiated | Bernstein | Outperform |
| Apr-26-18 | Reiterated | Needham | Strong Buy |
View All
Boston Scientific Corp Stock (BSX) Latest News
Technical signs of recovery in Boston Scientific CorporationMarket Risk Report & Free Reliable Trade Execution Plans - newser.com
Do Wall Street Analysts Like Boston Scientific Stock? - MSN
Can Boston Scientific Corporation stock test all time highs2025 Risk Factors & Long-Term Growth Portfolio Plans - newser.com
What market sentiment indicators show for Boston Scientific Corporation stockM&A Rumor & Safe Entry Zone Identification - newser.com
Is Boston Scientific Corporation stock a smart buy before Fed meetingQuarterly Performance Summary & Expert Curated Trade Ideas - newser.com
Lockheed Martin Investment Management Co. Lowers Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Is Boston Scientific (BSX) Becoming the Leading MedTech Growth Story? - Insider Monkey
Heritage Investors Management Corp Decreases Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
How Boston Scientific Corporation stock moves in volatile trading sessions2025 Trade Ideas & Consistent Growth Equity Picks - newser.com
Global Cardiac Monitoring Devices Market to Cross USD 30 Billion by 2032, Driven by Telehealth and Remote Monitoring Trends | DelveInsight - GlobeNewswire Inc.
Buy Boston Scientific Stock. It’s a Way to Diversify From AI? - Barron's
Looking to Diversify Away From AI? Buy Boston Scientific Stock. - Barron's
Risk vs reward if holding onto Boston Scientific CorporationTrade Risk Assessment & Daily Volume Surge Trade Alerts - newser.com
Chart based analysis of Boston Scientific Corporation trends2025 Price Action Summary & Weekly High Return Forecasts - newser.com
Canaccord Genuity Reiterates a Buy on Boston Scientific Corporation (BSX) - Insider Monkey
Can Boston Scientific Corporation stock sustain revenue momentumTrade Analysis Summary & Low Risk Entry Point Tips - newser.com
OVERSEA CHINESE BANKING Corp Ltd Has $259,000 Holdings in Boston Scientific Corporation $BSX - MarketBeat
5 Insightful Analyst Questions From Boston Scientific’s Q3 Earnings Call - Yahoo Finance
Ellen Zane Sells Shares of Boston Scientific Corp - GuruFocus
Private Wealth Partners LLC Sells 18,631 Shares of Boston Scientific Corporation $BSX - MarketBeat
Will Boston Scientific Corporation stock outperform Nasdaq indexWeekly Investment Summary & Growth Focused Entry Point Reports - fcp.pa.gov.br
BSX Stock Quote Price and Forecast - CNN
Will Boston Scientific Corporation stock gain from strong economyAnalyst Downgrade & Low Risk Profit Maximizing Plans - newser.com
How Boston Scientific Corporation stock performs after earningsJuly 2025 PreEarnings & Smart Money Movement Alerts - fcp.pa.gov.br
Is Boston Scientific Corporation stock ready for a breakoutShort Setup & Daily Technical Forecast Reports - newser.com
EPS Watch: Will Boston Scientific Corporation stock justify high valuationJuly 2025 Earnings & AI Enhanced Trading Alerts - fcp.pa.gov.br
Boston Scientific’s Innovative Approach to Gastric Outlet Obstruction: Study Update - TipRanks
Boston Scientific’s SIMPLAAFY Trial: A New Frontier in Atrial Fibrillation Treatment - TipRanks
Boston Scientific’s Orbera365™ Study: A New Frontier in Weight Loss Management - TipRanks
Boston Scientific’s New Study on Pacemaker Leads: What Investors Need to Know - TipRanks
Boston Scientific’s RHAPSODY Study: A Step Forward in Cardiac Care Innovation - TipRanks
Boston Scientific’s Hot AXIOS™ Stent Study: A Potential Game-Changer in Bile Duct Drainage - TipRanks
Boston Scientific’s Innovative Approach to Atrial Fibrillation: A Study Update - TipRanks
Boston Scientific’s Vercise™ DBS Study: A Real-World Evaluation of Dystonia Treatment - TipRanks
Boston Scientific shares positive Agent drug-coated balloon findings - MassDevice
Does Boston Scientific (BSX) Have the Potential to Rally 25.61% as Wall Street Analysts Expect? - Yahoo Finance
Bessemer Group Inc. Has $313.62 Million Position in Boston Scientific Corporation $BSX - MarketBeat
Schmidt P J Investment Management Inc. Boosts Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Is Boston Scientific Corporation stock a buy in volatile marketsWeekly Trend Recap & Accurate Technical Buy Alerts - newser.com
Boston Scientific Hits Day High with 3.95% Surge, Outperforming S&P 500 - Markets Mojo
Comparing Boston Scientific Corporation in custom built stock radarsMarket Growth Summary & Real-Time Chart Breakout Alerts - newser.com
Evaluating Boston Scientific Corporation with trendline analysisJuly 2025 Selloffs & Precise Swing Trade Alerts - newser.com
Boston Scientific (NYSE:BSX) Earns Buy (B-) Rating from Weiss Ratings - MarketBeat
Boston Scientific Corp Stock (BSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):